ellaOne
Description: Emergency contraceptive pill with ulipristal acetate (UPA).
Product Details
Duration: Single use
Regimen:
Dose: 30 mg
Active Pharmaceutical Ingredient (API):
Status Details
Status Details: - ellaOne was approved for use throughout the European Union by the European Medicines Agency (EMA) in 2009. Approved by the US FDA in 2010.
- Product is marketed in over 60 countries.
- ellaOne was approved for use throughout the European Union by the European Medicines Agency (EMA) in 2009. Approved by the US FDA in 2010.
- Product is marketed in over 60 countries.
Additional Information
References: HRA Pharma website: http://www.hra-pharma.com/index.php/en/our_products/womens_health
Gemzell-Danielsson, K. Meng C. (2010). Emergency contraception: potential role of ulipristal acetate. International Journal of Women's Health. 2:53-61.
HRA Pharma website: http://www.hra-pharma.com/index.php/en/our_products/womens_health
Gemzell-Danielsson, K. Meng C. (2010). Emergency contraception: potential role of ulipristal acetate. International Journal of Women's Health. 2:53-61.